Login/Sign Up
Versavo 100 Solution For Infusion 4 ml is a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. Cancer can start in one region of the body and spread to other parts. This is referred to as metastasis.
Versavo 100 Solution For Infusion 4 ml contains 'Bevacizumab' that works against vascular endothelial growth factor (VEGF) which is found on the lining of lymph and blood vessels. VEGF causes blood vessels to grow within tumours which provide oxygen and nutrients to the tumour. Inhibition of vascular endothelial growth factor limits the flow of oxygen and nutrients to the tumour, causing it to shrink or cease developing. Thus, it helps treat cancers.
Versavo 100 Solution For Infusion 4 ml will be administered by a healthcare professional; do not self-administer. Based on your medical condition, your doctor will decide the dose and duration. In some cases, Versavo 100 Solution For Infusion 4 ml may cause loss of appetite, constipation, fever, nosebleeds, change in speech, and taste. The majority of these side effects do not require medical treatment and fade away with time. However, consult your doctor if the side effects persist or worsen
Avoid taking Versavo 100 Solution For Infusion 4 ml if you are pregnant. Use effective contraception during the treatment and for 6months after the last dose. Versavo 100 Solution For Infusion 4 ml may cause sleepiness and fainting, so avoid driving while on treatment with Versavo 100 Solution For Infusion 4 ml. Do not breastfeed during the treatment and for 6months after the last dose of Versavo 100 Solution For Infusion 4 ml. Keep your doctor informed about your health condition and all the medicines you take to rule out any side effects.
Versavo 100 Solution For Infusion 4 ml contains Bevacizumab, a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Versavo 100 Solution For Infusion 4 ml works against a protein called vascular endothelial growth factor (VEGF). Vascular endothelial growth factor (VEGF) inhibition limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thus, it helps treat cancer.
Versavo 100 Solution For Infusion 4 ml should only be taken under medical supervision. While taking Versavo 100 Solution For Infusion 4 ml, the doctor will monitor your condition on a regular basis. If you have a history of allergic reactions to Versavo 100 Solution For Infusion 4 ml or other medications, inform your doctor before taking it. Avoid taking Versavo 100 Solution For Infusion 4 ml if you are pregnant. Use effective contraception during the treatment and for 6months after the last dose. Versavo 100 Solution For Infusion 4 ml may cause sleepiness and fainting, so avoid driving while on treatment with Versavo 100 Solution For Infusion 4 ml. Inform your doctor if you have/had high blood pressure, heart attack, stroke, bleeding problems, stomach/intestinal bleeding, perforation; if you had surgery in the past 28days/are due to have surgery. Do not breastfeed during the treatment and for 6months after the last dose of Versavo 100 Solution For Infusion 4 ml. While taking Versavo 100 Solution For Infusion 4 ml, please do not get any immunizations or vaccinations unless your doctor has approved it. Versavo 100 Solution For Infusion 4 ml may increase the risk of bleeding, so be cautious and consult your doctor if you notice any bleeding or bruising.
Drug-Drug Interactions: Versavo 100 Solution For Infusion 4 ml may have interaction with a drug used to treat renal and gastrointestinal cancer (sunitinib) and platinum or taxane-based therapies for lung or metastatic breast cancer. Inform your doctor if you have recently received, or are receiving, radiotherapy.
Drug-Food Interactions: Avoid the consumption of alcohol while taking Versavo 100 Solution For Infusion 4 ml.
Drug-Disease Interactions: Inform your doctor if you have/had infections, bleeding disorders, fistula formation (an abnormal connection between two body parts), GI perforation, hypertension, PRES (Posterior Reversible Encephalopathy Syndrome), proteinuria (abnormal quantities of protein in the urine), and thromboembolic disorders.
Cancer: It is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs. Cancer sometimes begins in one part of the body and spreads to other areas. It occurs due to mutations in genes that regulate cell growth. The mutations cause the cells to divide and multiply in an uncontrolled manner, leading to tumour formation. The most common cancer treatment methods are surgery, chemotherapy, radiotherapy, bone marrow (stem cell) transplantation, immunotherapy, and targeted drug therapy.
About Versavo 100 Solution For Infusion 4 ml
Versavo 100 Solution For Infusion 4 ml is a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. Cancer can start in one region of the body and spread to other parts. This is referred to as metastasis.
Versavo 100 Solution For Infusion 4 ml contains 'Bevacizumab' that works against vascular endothelial growth factor (VEGF) which is found on the lining of lymph and blood vessels. VEGF causes blood vessels to grow within tumours which provide oxygen and nutrients to the tumour. Inhibition of vascular endothelial growth factor limits the flow of oxygen and nutrients to the tumour, causing it to shrink or cease developing. Thus, it helps treat cancers.
Versavo 100 Solution For Infusion 4 ml will be administered by a healthcare professional; do not self-administer. Based on your medical condition, your doctor will decide the dose and duration. In some cases, Versavo 100 Solution For Infusion 4 ml may cause loss of appetite, constipation, fever, nosebleeds, change in speech, and taste. The majority of these side effects do not require medical treatment and fade away with time. However, consult your doctor if the side effects persist or worsen
Avoid taking Versavo 100 Solution For Infusion 4 ml if you are pregnant. Use effective contraception during the treatment and for 6months after the last dose. Versavo 100 Solution For Infusion 4 ml may cause sleepiness and fainting, so avoid driving while on treatment with Versavo 100 Solution For Infusion 4 ml. Do not breastfeed during the treatment and for 6months after the last dose of Versavo 100 Solution For Infusion 4 ml. Keep your doctor informed about your health condition and all the medicines you take to rule out any side effects.
₹6302.5*
MRP ₹7686
18% off
₹6533.1*
MRP ₹7686
15% CB
₹1152.9 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Online payment accepted
Product Substitutes
Uses of Versavo 100 Solution For Infusion 4 ml
Medicinal Benefits
Versavo 100 Solution For Infusion 4 ml contains Bevacizumab, a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Versavo 100 Solution For Infusion 4 ml works against a protein called vascular endothelial growth factor (VEGF). Vascular endothelial growth factor (VEGF) inhibition limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thus, it helps treat cancer.
Side Effects of Versavo 100 Solution For Infusion 4 ml
Directions for Use
Storage
Drug Warnings
Versavo 100 Solution For Infusion 4 ml should only be taken under medical supervision. While taking Versavo 100 Solution For Infusion 4 ml, the doctor will monitor your condition on a regular basis. If you have a history of allergic reactions to Versavo 100 Solution For Infusion 4 ml or other medications, inform your doctor before taking it. Avoid taking Versavo 100 Solution For Infusion 4 ml if you are pregnant. Use effective contraception during the treatment and for 6months after the last dose. Versavo 100 Solution For Infusion 4 ml may cause sleepiness and fainting, so avoid driving while on treatment with Versavo 100 Solution For Infusion 4 ml. Inform your doctor if you have/had high blood pressure, heart attack, stroke, bleeding problems, stomach/intestinal bleeding, perforation; if you had surgery in the past 28days/are due to have surgery. Do not breastfeed during the treatment and for 6months after the last dose of Versavo 100 Solution For Infusion 4 ml. While taking Versavo 100 Solution For Infusion 4 ml, please do not get any immunizations or vaccinations unless your doctor has approved it. Versavo 100 Solution For Infusion 4 ml may increase the risk of bleeding, so be cautious and consult your doctor if you notice any bleeding or bruising.
Therapeutic Class
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Cancer: It is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs. Cancer sometimes begins in one part of the body and spreads to other areas. It occurs due to mutations in genes that regulate cell growth. The mutations cause the cells to divide and multiply in an uncontrolled manner, leading to tumour formation. The most common cancer treatment methods are surgery, chemotherapy, radiotherapy, bone marrow (stem cell) transplantation, immunotherapy, and targeted drug therapy.